Back to Search
Start Over
The differential response to anti IL-6 treatment in COVID-19: the genetic counterpart.
- Source :
-
Clinical and experimental rheumatology [Clin Exp Rheumatol] 2020 May-Jun; Vol. 38 (3), pp. 580. Date of Electronic Publication: 2020 May 10. - Publication Year :
- 2020
- Subjects :
- Aged
Aged, 80 and over
Antibodies, Monoclonal, Humanized therapeutic use
Antigens, CD genetics
Antigens, Differentiation, T-Lymphocyte genetics
Arthritis, Rheumatoid drug therapy
Arthritis, Rheumatoid genetics
Betacoronavirus
COVID-19
Humans
Lectins, C-Type genetics
Middle Aged
Pandemics
Polymorphism, Single Nucleotide
Receptors, Interleukin-6 genetics
SARS-CoV-2
Adaptor Proteins, Signal Transducing genetics
Coronavirus Infections drug therapy
Coronavirus Infections genetics
Interleukin-6 antagonists & inhibitors
Pneumonia, Viral drug therapy
Pneumonia, Viral genetics
Subjects
Details
- Language :
- English
- ISSN :
- 0392-856X
- Volume :
- 38
- Issue :
- 3
- Database :
- MEDLINE
- Journal :
- Clinical and experimental rheumatology
- Publication Type :
- Editorial & Opinion
- Accession number :
- 32452345